260 related articles for article (PubMed ID: 19761811)
1. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database.
Kondo C; Minowa Y; Uehara T; Okuno Y; Nakatsu N; Ono A; Maruyama T; Kato I; Yamate J; Yamada H; Ohno Y; Urushidani T
Toxicology; 2009 Nov; 265(1-2):15-26. PubMed ID: 19761811
[TBL] [Abstract][Full Text] [Related]
2. Toxicogenomic multigene biomarker for predicting the future onset of proximal tubular injury in rats.
Minowa Y; Kondo C; Uehara T; Morikawa Y; Okuno Y; Nakatsu N; Ono A; Maruyama T; Kato I; Yamate J; Yamada H; Ohno Y; Urushidani T
Toxicology; 2012 Jul; 297(1-3):47-56. PubMed ID: 22503706
[TBL] [Abstract][Full Text] [Related]
3. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers.
Thukral SK; Nordone PJ; Hu R; Sullivan L; Galambos E; Fitzpatrick VD; Healy L; Bass MB; Cosenza ME; Afshari CA
Toxicol Pathol; 2005; 33(3):343-55. PubMed ID: 15805072
[TBL] [Abstract][Full Text] [Related]
4. Validation of putative genomic biomarkers of nephrotoxicity in rats.
Wang EJ; Snyder RD; Fielden MR; Smith RJ; Gu YZ
Toxicology; 2008 Apr; 246(2-3):91-100. PubMed ID: 18289764
[TBL] [Abstract][Full Text] [Related]
5. A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity.
Fielden MR; Eynon BP; Natsoulis G; Jarnagin K; Banas D; Kolaja KL
Toxicol Pathol; 2005; 33(6):675-83. PubMed ID: 16239200
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential genomic biomarkers of hepatotoxicity caused by reactive metabolites of N-methylformamide: Application of stable isotope labeled compounds in toxicogenomic studies.
Mutlib A; Jiang P; Atherton J; Obert L; Kostrubsky S; Madore S; Nelson S
Chem Res Toxicol; 2006 Oct; 19(10):1270-83. PubMed ID: 17040096
[TBL] [Abstract][Full Text] [Related]
7. Scoring multiple toxicological endpoints using a toxicogenomic database.
Kiyosawa N; Ando Y; Watanabe K; Niino N; Manabe S; Yamoto T
Toxicol Lett; 2009 Jul; 188(2):91-7. PubMed ID: 19446240
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
[TBL] [Abstract][Full Text] [Related]
9. Acute hepatotoxicity: a predictive model based on focused illumina microarrays.
Zidek N; Hellmann J; Kramer PJ; Hewitt PG
Toxicol Sci; 2007 Sep; 99(1):289-302. PubMed ID: 17522070
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether ("compound A") in rats.
Kharasch ED; Schroeder JL; Bammler T; Beyer R; Srinouanprachanh S
Toxicol Sci; 2006 Apr; 90(2):419-31. PubMed ID: 16384817
[TBL] [Abstract][Full Text] [Related]
11. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
[TBL] [Abstract][Full Text] [Related]
12. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.
Harpur E; Ennulat D; Hoffman D; Betton G; Gautier JC; Riefke B; Bounous D; Schuster K; Beushausen S; Guffroy M; Shaw M; Lock E; Pettit S;
Toxicol Sci; 2011 Aug; 122(2):235-52. PubMed ID: 21593213
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and tissue indicators of para-aminophenol nephrotoxicity in sprague-dawley rats.
Yang A; Trajkovic D; Illanes O; Ramiro-Ibáñez F
Toxicol Pathol; 2007 Jun; 35(4):521-32. PubMed ID: 17562485
[TBL] [Abstract][Full Text] [Related]
14. In vitro gene expression analysis of nephrotoxic drugs in rat primary renal cortical tubular cells.
Suzuki H; Inoue T; Matsushita T; Kobayashi K; Horii I; Hirabayashi Y; Inoue T
J Appl Toxicol; 2008 Mar; 28(2):237-48. PubMed ID: 18172885
[TBL] [Abstract][Full Text] [Related]
15. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
Merrick BA; Bruno ME
Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential genomic biomarkers for early detection of chemically induced cardiotoxicity in rats.
Mori Y; Kondo C; Tonomura Y; Torii M; Uehara T
Toxicology; 2010 Apr; 271(1-2):36-44. PubMed ID: 20211217
[TBL] [Abstract][Full Text] [Related]
17. Effect of the difference in vehicles on gene expression in the rat liver--analysis of the control data in the Toxicogenomics Project Database.
Takashima K; Mizukawa Y; Morishita K; Okuyama M; Kasahara T; Toritsuka N; Miyagishima T; Nagao T; Urushidani T
Life Sci; 2006 May; 78(24):2787-96. PubMed ID: 16360708
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic Acid.
Betton GR; Ennulat D; Hoffman D; Gautier JC; Harpur E; Pettit S
Toxicol Pathol; 2012 Jun; 40(4):682-94. PubMed ID: 22301952
[TBL] [Abstract][Full Text] [Related]
19. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database.
Uehara T; Minowa Y; Morikawa Y; Kondo C; Maruyama T; Kato I; Nakatsu N; Igarashi Y; Ono A; Hayashi H; Mitsumori K; Yamada H; Ohno Y; Urushidani T
Toxicol Appl Pharmacol; 2011 Sep; 255(3):297-306. PubMed ID: 21784091
[TBL] [Abstract][Full Text] [Related]
20. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.
Nie AY; McMillian M; Parker JB; Leone A; Bryant S; Yieh L; Bittner A; Nelson J; Carmen A; Wan J; Lord PG
Mol Carcinog; 2006 Dec; 45(12):914-33. PubMed ID: 16921489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
